The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: Acute exacerbations of chronic hepatitis B (CHB-AEs) are common in endemic areas and are often presumed to be acute hepatitis B (AHB) due to their similarities in clinical and serological pictures, presenting a major diagnostic dilemma. This study aimed to identify laboratory markers for differentiating between the two groups, and to establish the cut-off value for significant markers. Methods: A retrospective analysis of records was conducted for patients who presented with clinical features of acute hepatitis along with hepatitis B surface antigen (HBsAg) and IgM antibody to hepatitis B core antigen (IgM anti-HBc) positivity from May 2015 to May 2017. A total of 172 patients were enrolled and grouped as AHB (n=89) and CHB-AE (n=83) based on their history of hepatitis B virus infection and duration of HBsAg persistence. Virological and biochemical parameters were analyzed and compared. Cut-off values, sensitivity, and specificity of the variables were calculated. Results: The median value of signal by cut-off (S/Co) ratio for IgM anti-HBc was significantly higher in AHB group (30.44) compared to CHB-AE group (8.63) with a sensitivity and specificity of 97% and 84%, respectively, at a cut-off of 20.5 (P<0.01). The mean international normalized ratio (INR) was significantly greater in CHB-AE (1.88±1.24) group compared to AHB group (1.62±0.17) with a sensitivity and specificity of 57.9% and 45.1%, respectively, at a cut-off value of 1.27. Conclusions: A value of 20.5 S/Co of IgM anti-HBc and 1.27 INR could be helpful in differentiating between AHB and CHB-AE.
Abstract
Background/Aims: Acute exacerbations of chronic hepatitis B (CHB-AEs) are common in endemic areas and are often presumed to be acute hepatitis B (AHB) due to their similarities in clinical and serological pictures, presenting a major diagnostic dilemma. This study aimed to identify laboratory markers for differentiating between the two groups, and to establish the cut-off value for significant markers. Methods: A retrospective analysis of records was conducted for patients who presented with clinical features of acute hepatitis along with hepatitis B surface antigen (HBsAg) and IgM antibody to hepatitis B core antigen (IgM anti-HBc) positivity from May 2015 to May 2017. A total of 172 patients were enrolled and grouped as AHB (n=89) and CHB-AE (n=83) based on their history of hepatitis B virus infection and duration of HBsAg persistence. Virological and biochemical parameters were analyzed and compared. Cut-off values, sensitivity, and specificity of the variables were calculated. Results: The median value of signal by cut-off (S/Co) ratio for IgM anti-HBc was significantly higher in AHB group (30.44) compared to CHB-AE group (8.63) with a sensitivity and specificity of 97% and 84%, respectively, at a cut-off of 20.5 (P<0.01). The mean international normalized ratio (INR) was significantly greater in CHB-AE (1.88±1.24) group compared to AHB group (1.62±0.17) with a sensitivity and specificity of 57.9% and 45.1%, respectively, at a cut-off value of 1.27. Conclusions: A value of 20.5 S/Co of IgM anti-HBc and 1.27 INR could be helpful in differentiating between AHB and CHB-AE.
참고문헌 (31)
- "Hepatitis B. World health Organization Global hepatitis report 2017"[URL]
- Lavanchy D, "Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures", J Viral Hepat, 11, pp.97~107 (2004)
- Puri P, "Tackling the hepatitis B disease burden in India", J Clin Exp Hepatol, 4, pp.312~319 (2014)
- Maruyama T, "Distinguishing between acute and symptomatic chronic Hepatitis B virus infection", Gastroenterology, 106, pp.1006~1015 (1994)
- Maruyama T, "Serology of acute exacerbation in chronic hepatitis B virus infection", Gastroenterology, 105, pp.1141~1151 (1993)
- Sarin SK, "Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update", Hepatol Int, 10, pp.1~98 (2016)
- Davis GL, "Reactivation of chronic type B hepatitis presenting as acute viral hepatitis", Ann Intern Med, 102, pp.762~765 (1985)
- Chu CM, "The aetiology of acute hepatitis in Taiwan : acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate", Infection, 16, pp.233~237 (1988)
- Liaw YF, "The etiology of acute viral hepatitis in an endemic area of hepatitis A and B", Am J Trop Med Hyg, 32, pp.1401~1406 (1983)
- Tassopoulos NC, "Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults", Gastroenterology, 92, pp.1844~1850 (1987)
- Puri P, "Acute exacerbation of chronic hepatitis B : the dilemma of differentiation from acute viral hepatitis B", J Clin Exp Hepatol, 3, pp.301~312 (2013)
- Kryger P, "Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers", Hepatology, 1, pp.233~237 (1981)
- Papaevangelou G, "Diagnostic value of anti-HBc IgM in high HBV prevalence areas", J Med Virol, 13, pp.393~399 (1984)
- Santos MV, "Acute exacerbation in chronic hepatitis B virus infection", Rev Soc Bras Med Trop, 29, pp.275~279 (1996)
- Miller DJ, "Seroepidemiology of viral hepatitis : correlation with clinical findings", Postgrad Med, 68, pp.137~141 (1980)
- Rodella A, "Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B", J Clin Virol, 37, pp.206~212 (2006)
- Huang YW, "Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B", J Gastroenterol Hepatol, 21, pp.859~862 (2006)
- Han Y, "Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare", J Gastroenterol Hepatol, 23, pp.1728~1733 (2008)
- Kumar M, "Differentiating acute hepatitis B from first episode of symptomatic exacerbation of chronic hepatitis B", Dig Dis Sci, 51, pp.594~599 (2006)
- Dao DY, "Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti hepatitis B core antibody and hepatitis B virus DNA levels", Hepatology, 55, pp.676~684 (2012)
- Park JW, "Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients", World J Gastroenterol, 21, pp.3953~3959 (2015)
- Okada K, "e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants", N Engl J Med, 294, pp.746~749 (1976)
- Hoofnagle JH, "Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis", Ann Intern Med, 94, pp.744~748 (1981)
- Frösner GG, "Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection", Eur J ClinMicrobiol, 1, pp.52~58 (1982)
- Chulanov VP, "Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses", J Med Virol, 69, pp.313~323 (2003)
- Chen CH, "Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers", Eur J Gastroenterol Hepatol, 16, pp.1213~1218 (2004)
- Giannini E, "Validity and clinical utility of the Aspartate aminotransferasealanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease", Arch Intern Med, 163, pp.218~224 (2003)
- Sebastiani G, "Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B", World J Gastroenterol, 13, pp.525~531 (2007)
- Wai CT, "A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C", Hepatology, 38, pp.518~526 (2003)
- Castera L, "Noninvasive methods to assess liver disease in patients with hepatitis B or C", Gastroenterology, 142, pp.1293~1302.e4 (2012)
- Jindal A, "Management of acute hepatitis B and reactivation of hepatitis B", Liver Int, 33(Suppl 1), pp.164~175 (2013)